These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15389579)

  • 1. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
    Baroni T; Carinci P; Lilli C; Bellucci C; Aisa MC; Scapoli L; Volinia S; Carinci F; Pezzetti F; Calvitti M; Farina A; Conte C; Bodo M
    J Cell Physiol; 2005 Feb; 202(2):524-35. PubMed ID: 15389579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
    Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
    J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
    Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
    Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.
    Lemonnier J; Haÿ E; Delannoy P; Lomri A; Modrowski D; Caverzasio J; Marie PJ
    J Bone Miner Res; 2001 May; 16(5):832-45. PubMed ID: 11341328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures.
    Zhou YX; Xu X; Chen L; Li C; Brodie SG; Deng CX
    Hum Mol Genet; 2000 Aug; 9(13):2001-8. PubMed ID: 10942429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1.
    Lemonnier J; Haÿ E; Delannoy P; Fromigué O; Lomri A; Modrowski D; Marie PJ
    Am J Pathol; 2001 May; 158(5):1833-42. PubMed ID: 11337381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
    Lomri A; Lemonnier J; Delannoy P; Marie PJ
    J Bone Miner Res; 2001 Apr; 16(4):705-12. PubMed ID: 11315998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
    Guenou H; Kaabeche K; Mée SL; Marie PJ
    Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.
    Fragale A; Tartaglia M; Bernardini S; Di Stasi AM; Di Rocco C; Velardi F; Teti A; Battaglia PA; Migliaccio S
    Am J Pathol; 1999 May; 154(5):1465-77. PubMed ID: 10329600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
    Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
    Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
    Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
    Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
    Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
    J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
    Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
    Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
    Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
    Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
    J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice.
    Myo AC; Kobayashi Y; Niki Y; Kamimoto H; Moriyama K
    Arch Oral Biol; 2023 Sep; 153():105753. PubMed ID: 37348363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells.
    Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M
    Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
    Ratisoontorn C; Fan GF; McEntee K; Nah HD
    Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.